APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Companion Animals Medicines and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Companion Animals Medicines and Vaccines Market Outlook and Growth Opportunities 2026

Report ID 17398011042 January 2026195 pages

Choose your research edition.

Industry ResearchCompanion Animals Medicines and Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Companion Animals Medicines and Vaccines Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Companion Animals Medicines and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Companion Animals Medicines and Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Companion Animals Medicines and Vaccines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Companion Animals Medicines and Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Companion Animals Medicines and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Companion Animals Medicines and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Companion Animals Medicines and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Companion Animals Medicines and Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Companion Animals Medicines and Vaccines market include Boehringer Ingelheim, Ceva, Dechra Veterinary Products, Elanco Animal Health, Meiji, Ouro Fino Saude, Parnell, Vetoquinol and Virbac, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Companion Animals Medicines and Vaccines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Companion Animals Medicines and Vaccines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Companion Animals Medicines and Vaccines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Companion Animals Medicines and Vaccines market.

Companion Animals Medicines and Vaccines Segment by Company

Boehringer Ingelheim

Ceva

Dechra Veterinary Products

Elanco Animal Health

Meiji

Ouro Fino Saude

Parnell

Vetoquinol

Virbac

Zoetis

Bayer Animal Health

Merck Animal Health

Companion Animals Medicines and Vaccines Segment by Type

Medicines

Vaccines

Companion Animals Medicines and Vaccines Segment by Application

Dogs

Cats

Other

Companion Animals Medicines and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Companion Animals Medicines and Vaccines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Companion Animals Medicines and Vaccines key companies, revenue, market share, and recent developments.

3. To split the Companion Animals Medicines and Vaccines breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Companion Animals Medicines and Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Companion Animals Medicines and Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Companion Animals Medicines and Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animals Medicines and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Companion Animals Medicines and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animals Medicines and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Companion Animals Medicines and Vaccines industry.

Chapter 3: Detailed analysis of Companion Animals Medicines and Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Companion Animals Medicines and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Companion Animals Medicines and Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Companion Animals Medicines and Vaccines Industry Trends Table 2. Companion Animals Medicines and Vaccines Industry Drivers Table 3. Companion Animals Medicines and Vaccines Industry Opportunities and Challenges Table 4. Companion Animals Medicines and Vaccines Industry Restraints Table 5. Global Companion Animals Medicines and Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Companion Animals Medicines and Vaccines Revenue Share by Company (2021-2026) Table 7. Global Companion Animals Medicines and Vaccines Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Companion Animals Medicines and Vaccines Key Company Manufacturing Base & Headquarters Table 9. Global Companion Animals Medicines and Vaccines Company, Product Type & Application Table 10. Global Companion Animals Medicines and Vaccines Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Companion Animals Medicines and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Medicines Table 15. Significant Companies of Vaccines Table 16. Global Companion Animals Medicines and Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Companion Animals Medicines and Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Companion Animals Medicines and Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Companion Animals Medicines and Vaccines Sales Value Share by Type (2021-2026) Table 20. Global Companion Animals Medicines and Vaccines Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Dogs Table 22. Significant Companies of Cats Table 23. Significant Companies of Other Table 24. Global Companion Animals Medicines and Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Companion Animals Medicines and Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Companion Animals Medicines and Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Companion Animals Medicines and Vaccines Sales Value Share by Application (2021-2026) Table 28. Global Companion Animals Medicines and Vaccines Sales Value Share by Application (2027-2032) Table 29. Global Companion Animals Medicines and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Companion Animals Medicines and Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Companion Animals Medicines and Vaccines Sales Value Share by Region (2021-2026) Table 32. Global Companion Animals Medicines and Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Companion Animals Medicines and Vaccines Sales Value Share by Region (2027-2032) Table 34. Global Companion Animals Medicines and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Companion Animals Medicines and Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Companion Animals Medicines and Vaccines Sales Value Market Share by Country (2021-2026) Table 37. Global Companion Animals Medicines and Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Companion Animals Medicines and Vaccines Sales Value Market Share by Country (2027-2032) Table 39. Boehringer Ingelheim Company Information Table 40. Boehringer Ingelheim Business Overview Table 41. Boehringer Ingelheim Companion Animals Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Boehringer Ingelheim Companion Animals Medicines and Vaccines Product Portfolio Table 43. Boehringer Ingelheim Recent Development Table 44. Ceva Company Information Table 45. Ceva Business Overview Table 46. Ceva Companion Animals Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Ceva Companion Animals Medicines and Vaccines Product Portfolio Table 48. Ceva Recent Development Table 49. Dechra Veterinary Products Company Information Table 50. Dechra Veterinary Products Business Overview Table 51. Dechra Veterinary Products Companion Animals Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Dechra Veterinary Products Companion Animals Medicines and Vaccines Product Portfolio Table 53. Dechra Veterinary Products Recent Development Table 54. Elanco Animal Health Company Information Table 55. Elanco Animal Health Business Overview Table 56. Elanco Animal Health Companion Animals Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Elanco Animal Health Companion Animals Medicines and Vaccines Product Portfolio Table 58. Elanco Animal Health Recent Development Table 59. Meiji Company Information Table 60. Meiji Business Overview Table 61. Meiji Companion Animals Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Meiji Companion Animals Medicines and Vaccines Product Portfolio Table 63. Meiji Recent Development Table 64. Ouro Fino Saude Company Information Table 65. Ouro Fino Saude Business Overview Table 66. Ouro Fino Saude Companion Animals Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Ouro Fino Saude Companion Animals Medicines and Vaccines Product Portfolio Table 68. Ouro Fino Saude Recent Development Table 69. Parnell Company Information Table 70. Parnell Business Overview Table 71. Parnell Companion Animals Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Parnell Companion Animals Medicines and Vaccines Product Portfolio Table 73. Parnell Recent Development Table 74. Vetoquinol Company Information Table 75. Vetoquinol Business Overview Table 76. Vetoquinol Companion Animals Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Vetoquinol Companion Animals Medicines and Vaccines Product Portfolio Table 78. Vetoquinol Recent Development Table 79. Virbac Company Information Table 80. Virbac Business Overview Table 81. Virbac Companion Animals Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Virbac Companion Animals Medicines and Vaccines Product Portfolio Table 83. Virbac Recent Development Table 84. Zoetis Company Information Table 85. Zoetis Business Overview Table 86. Zoetis Companion Animals Medicines and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Zoetis Companion Animals Medicines and Vaccines Product Portfolio Table 88. Zoetis Recent Development Table 89. Bayer Animal Health Company Information Table 90. Bayer Animal Health Business Overview Table 91. Bayer Animal Health Companion Animals Medicines and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Bayer Animal Health Companion Animals Medicines and Vaccines Product Portfolio Table 93. Bayer Animal Health Recent Development Table 94. Merck Animal Health Company Information Table 95. Merck Animal Health Business Overview Table 96. Merck Animal Health Companion Animals Medicines and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Merck Animal Health Companion Animals Medicines and Vaccines Product Portfolio Table 98. Merck Animal Health Recent Development Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Companion Animals Medicines and Vaccines Product Image Figure 2. Global Companion Animals Medicines and Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Companion Animals Medicines and Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Medicines Image Figure 8. Vaccines Image Figure 9. Global Companion Animals Medicines and Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Companion Animals Medicines and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Companion Animals Medicines and Vaccines Sales Value Share by Type (2021-2032) Figure 12. Dogs Image Figure 13. Cats Image Figure 14. Other Image Figure 15. Global Companion Animals Medicines and Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Companion Animals Medicines and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Companion Animals Medicines and Vaccines Sales Value Share by Application (2021-2032) Figure 18. Global Companion Animals Medicines and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Companion Animals Medicines and Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Companion Animals Medicines and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 21. North America Companion Animals Medicines and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Companion Animals Medicines and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Companion Animals Medicines and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Companion Animals Medicines and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Companion Animals Medicines and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Companion Animals Medicines and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 27. South America Companion Animals Medicines and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Companion Animals Medicines and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Companion Animals Medicines and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Medicines
  • Vaccines
Applications
  • Dogs
  • Cats
  • Other
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Dechra Veterinary Products
  • Elanco Animal Health
  • Meiji
  • Ouro Fino Saude
  • Parnell
  • Vetoquinol
  • Virbac
  • Zoetis
  • Bayer Animal Health
  • Merck Animal Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Companion Animals Medicines and Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Companion Animals Medicines and Vaccines Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Companion Animals Medicines and Vaccines Market Dynamics
  1. 2.1 Companion Animals Medicines and Vaccines Industry Trends
  2. 2.2 Companion Animals Medicines and Vaccines Industry Drivers
  3. 2.3 Companion Animals Medicines and Vaccines Industry Opportunities and Challenges
  4. 2.4 Companion Animals Medicines and Vaccines Industry Restraints
3 Companion Animals Medicines and Vaccines Market by Company
  1. 3.1 Global Companion Animals Medicines and Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Companion Animals Medicines and Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Companion Animals Medicines and Vaccines Company Ranking (2024-2026)
  4. 3.4 Global Companion Animals Medicines and Vaccines Company Manufacturing Base and Headquarters
  5. 3.5 Global Companion Animals Medicines and Vaccines Company Product Type and Application
  6. 3.6 Global Companion Animals Medicines and Vaccines Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Companion Animals Medicines and Vaccines Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Companion Animals Medicines and Vaccines Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Companion Animals Medicines and Vaccines Market by Type
  1. 4.1 Companion Animals Medicines and Vaccines Type Introduction
  2. 4.1.1 Medicines
  3. 4.1.2 Vaccines
  4. 4.2 Global Companion Animals Medicines and Vaccines Sales Value by Type
  5. 4.2.1 Global Companion Animals Medicines and Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Companion Animals Medicines and Vaccines Sales Value by Type (2021-2032)
  7. 4.2.3 Global Companion Animals Medicines and Vaccines Sales Value Share by Type (2021-2032)
5 Companion Animals Medicines and Vaccines Market by Application
  1. 5.1 Companion Animals Medicines and Vaccines Application Introduction
  2. 5.1.1 Dogs
  3. 5.1.2 Cats
  4. 5.1.3 Other
  5. 5.2 Global Companion Animals Medicines and Vaccines Sales Value by Application
  6. 5.2.1 Global Companion Animals Medicines and Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Companion Animals Medicines and Vaccines Sales Value by Application (2021-2032)
  8. 5.2.3 Global Companion Animals Medicines and Vaccines Sales Value Share by Application (2021-2032)
6 Companion Animals Medicines and Vaccines Regional Value Analysis
  1. 6.1 Global Companion Animals Medicines and Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Companion Animals Medicines and Vaccines Sales Value by Region (2021-2032)
  3. 6.2.1 Global Companion Animals Medicines and Vaccines Sales Value by Region: 2021-2026
  4. 6.2.2 Global Companion Animals Medicines and Vaccines Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Companion Animals Medicines and Vaccines Sales Value (2021-2032)
  7. 6.3.2 North America Companion Animals Medicines and Vaccines Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Companion Animals Medicines and Vaccines Sales Value (2021-2032)
  10. 6.4.2 Europe Companion Animals Medicines and Vaccines Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Companion Animals Medicines and Vaccines Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Companion Animals Medicines and Vaccines Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Companion Animals Medicines and Vaccines Sales Value (2021-2032)
  16. 6.6.2 South America Companion Animals Medicines and Vaccines Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Companion Animals Medicines and Vaccines Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Companion Animals Medicines and Vaccines Sales Value Share by Country, 2025 VS 2032
7 Companion Animals Medicines and Vaccines Country-level Value Analysis
  1. 7.1 Global Companion Animals Medicines and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Companion Animals Medicines and Vaccines Sales Value by Country (2021-2032)
  3. 7.2.1 Global Companion Animals Medicines and Vaccines Sales Value by Country (2021-2026)
  4. 7.2.2 Global Companion Animals Medicines and Vaccines Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Companion Animals Medicines and Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Companion Animals Medicines and Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Companion Animals Medicines and Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Companion Animals Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Companion Animals Medicines and Vaccines Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Ceva
  8. 8.2.1 Ceva Company Information
  9. 8.2.2 Ceva Business Overview
  10. 8.2.3 Ceva Companion Animals Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ceva Companion Animals Medicines and Vaccines Product Portfolio
  12. 8.2.5 Ceva Recent Developments
  13. 8.3 Dechra Veterinary Products
  14. 8.3.1 Dechra Veterinary Products Company Information
  15. 8.3.2 Dechra Veterinary Products Business Overview
  16. 8.3.3 Dechra Veterinary Products Companion Animals Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dechra Veterinary Products Companion Animals Medicines and Vaccines Product Portfolio
  18. 8.3.5 Dechra Veterinary Products Recent Developments
  19. 8.4 Elanco Animal Health
  20. 8.4.1 Elanco Animal Health Company Information
  21. 8.4.2 Elanco Animal Health Business Overview
  22. 8.4.3 Elanco Animal Health Companion Animals Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Animal Health Companion Animals Medicines and Vaccines Product Portfolio
  24. 8.4.5 Elanco Animal Health Recent Developments
  25. 8.5 Meiji
  26. 8.5.1 Meiji Company Information
  27. 8.5.2 Meiji Business Overview
  28. 8.5.3 Meiji Companion Animals Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Meiji Companion Animals Medicines and Vaccines Product Portfolio
  30. 8.5.5 Meiji Recent Developments
  31. 8.6 Ouro Fino Saude
  32. 8.6.1 Ouro Fino Saude Company Information
  33. 8.6.2 Ouro Fino Saude Business Overview
  34. 8.6.3 Ouro Fino Saude Companion Animals Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ouro Fino Saude Companion Animals Medicines and Vaccines Product Portfolio
  36. 8.6.5 Ouro Fino Saude Recent Developments
  37. 8.7 Parnell
  38. 8.7.1 Parnell Company Information
  39. 8.7.2 Parnell Business Overview
  40. 8.7.3 Parnell Companion Animals Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Parnell Companion Animals Medicines and Vaccines Product Portfolio
  42. 8.7.5 Parnell Recent Developments
  43. 8.8 Vetoquinol
  44. 8.8.1 Vetoquinol Company Information
  45. 8.8.2 Vetoquinol Business Overview
  46. 8.8.3 Vetoquinol Companion Animals Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vetoquinol Companion Animals Medicines and Vaccines Product Portfolio
  48. 8.8.5 Vetoquinol Recent Developments
  49. 8.9 Virbac
  50. 8.9.1 Virbac Company Information
  51. 8.9.2 Virbac Business Overview
  52. 8.9.3 Virbac Companion Animals Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Virbac Companion Animals Medicines and Vaccines Product Portfolio
  54. 8.9.5 Virbac Recent Developments
  55. 8.10 Zoetis
  56. 8.10.1 Zoetis Company Information
  57. 8.10.2 Zoetis Business Overview
  58. 8.10.3 Zoetis Companion Animals Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Zoetis Companion Animals Medicines and Vaccines Product Portfolio
  60. 8.10.5 Zoetis Recent Developments
  61. 8.11 Bayer Animal Health
  62. 8.11.1 Bayer Animal Health Company Information
  63. 8.11.2 Bayer Animal Health Business Overview
  64. 8.11.3 Bayer Animal Health Companion Animals Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bayer Animal Health Companion Animals Medicines and Vaccines Product Portfolio
  66. 8.11.5 Bayer Animal Health Recent Developments
  67. 8.12 Merck Animal Health
  68. 8.12.1 Merck Animal Health Company Information
  69. 8.12.2 Merck Animal Health Business Overview
  70. 8.12.3 Merck Animal Health Companion Animals Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Animal Health Companion Animals Medicines and Vaccines Product Portfolio
  72. 8.12.5 Merck Animal Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst